Puma Biotechnology, Inc. shares held by Auerbach
- 8,648,958 shares beneficially owned
- 16.0% of outstanding shares
- Warrant expired on 2026-10-04
Alan H Auerbach, filed by
Every EDGAR filing for PUMA BIOTECHNOLOGY, INC. (PBYI), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 6 · 10-Q expected ~Nov 6 (deadline Nov 9)
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Alan H Auerbach, filed by
Troy Edward Wilson, insider filing for PBYI
Troy Edward Wilson, reporting
Alessandra Cesano, planned sale of PBYI shares
Alessandra Cesano, reporting
Alan H Auerbach, insider filing for PBYI
Alan H Auerbach, reporting
Alan H Auerbach, planned sale of PBYI shares
Alan H Auerbach, reporting
Troy Edward Wilson, insider filing for PBYI
Troy Edward Wilson, reporting
Adrian Senderowicz, planned sale of PBYI shares
Adrian Senderowicz, reporting
Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
Maximo F Nougues, insider filing for PBYI
Maximo F Nougues, reporting
Alan H Auerbach, insider filing for PBYI
Alan H Auerbach, reporting
Alan H Auerbach, planned sale of PBYI shares
Alan H Auerbach, reporting
Maximo F Nougues, planned sale of PBYI shares
Maximo F Nougues, reporting
Michael Patrick Miller, reporting
Michael Patrick Miller, planned sale of PBYI shares
Michael Patrick Miller, reporting